Table 1. Patients and clinical characteristics.
n = 186 | P values * | |
---|---|---|
Median age, years (range) | 58 (19–78) | n.s. |
Male sex, no (%) | 83 (44.6) | n.s. |
Cytogenetic risk group | n.s. | |
good (%) | 20 (10.7) | |
intermediate (%) | 108 (58.1) | |
poor (%) | 58 (31.2) | |
WBC count at diagnosis (/nl), median (range) | 14.2 (0.3–330) | n.s. |
Platelet count at diagnosis (/nl), median (range) | 45 (2–332) | n.s. |
Hemoglobin level at diagnosis (mmol/l), median (range) | 5.7 (2.5–8.8) | n.s. |
Peripheral blood blasts (%), median (range) | 27 (0–99) | n.s. |
Bone marrow blasts (%), median (range) | 75 (17–99) | n.s. |
Outcome after induction chemotherapy | ||
Alive | 183 | |
Dead | 3 |
* P-values (calculated for IFD).
Abbreviation
WBC, white blood cell.